Agenus Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Antigenics
  • Aronex Pharmaceuticals
  • Agenus Royalty Fund
  • Agenus Switzerland
  • Agenus UK
  • 4-Antibody
  • AgenTus Therapeutics
  • Aquila Biopharmaceuticals
  • MiNK Therapeutics
  • PhosImmune
  • SaponiQx
See more in Biomedtracker

Latest on Agenus Inc.

Pink Sheet

US FDA Asking Questions About Commissioner’s Voucher Program With Details Scarce

 
• By Derrick Gingery

US Food and Drug Administration staff continue to wait for guidance on implementing the Commissioner’s National Priority Voucher (CNPV), with logistical, legal and other questions lingering. In the we

Scrip

Deal Watch: Lilly Licenses Camurus’s Delivery Technology For Long-Acting Incretins

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D

Scrip

BeiGene Ends Anti-TIGIT Development In Lung Cancer

 
• By Joseph Haas

The biopharma sector saw another setback for the once-hot anti-TIGIT class on 3 April as BeiGene said it would end a Phase III trial of its antibody candidate ociperlimab (BGB-A1217) in non-small cell

Scrip

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On

 
• By Mandy Jackson

Sutro Biopharma announced after the stock market closed on 13 March that as a result of a strategic portfolio review the company will end development of its one and only clinical-stage antibody drug c